4.7 Article

Macrophage immunomodulatory activity of polysaccharides isolated from Opuntia polyacantha

期刊

INTERNATIONAL IMMUNOPHARMACOLOGY
卷 8, 期 10, 页码 1455-1466

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2008.06.003

关键词

Opuntia polyacantha; polysaccharide; macrophage; reactive oxygen species; nitric oxide; cytokines

资金

  1. Department of Defense [W9113M-04-1-0001]
  2. National Institutes of Health [P20 RR-020185, U54 AI-065357, HHSN266200400009C]
  3. M.J. Murdock Charitable Trust
  4. Montana State University Agricultural Experimental Station

向作者/读者索取更多资源

Opuntia polyacantha (prickly pear cactus) has been used extensively for its nutritional properties; however, less is known regarding medicinal properties of Opuntia tissues. In the present study, we extracted polysaccharides from O. polyacantha and used size-exclusion chromatography to fractionate the crude polysaccharides into four polysaccharide fractions (designated as Opuntia polysaccharides C-I to C-IV). The average M(r) Of fractions C-I through C-IV was estimated to be 733, 550, 310, and 168 kDa, respectively, and sugar composition analysis revealed that Opuntia polysaccharides consisted primarily of galactose, galacturonic acid, xylose, arabinose, and rhamnose. Analysis of the effects of Opuntia polysaccharides on human and murine macrophages demonstrated that at( four fractions had potent immunomodulatory activity, inducing production of reactive oxygen species, nitric oxide, tumor necrosis factor a, and interleukin 6. Furthermore, modulation of macrophage function by Opuntia polysaccharides was mediated, at least in part, through activation of nuclear factor kappa B. Together, our results provide a molecular basis to explain a portion of the beneficial therapeutic properties of extracts from O. polyacantha and support the concept of using Opuntia polysaccharides as an immunotherapeutic adjuvant. (c) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据